
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7046258
[patent_doc_number] => 20050250853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Beta-tubulin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/072334
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8306
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250853.pdf
[firstpage_image] =>[orig_patent_app_number] => 11072334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/072334 | Beta-tubulin inhibitors | Mar 6, 2005 | Abandoned |
Array
(
[id] => 5895473
[patent_doc_number] => 20060004012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/067377
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41624
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20060004012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067377 | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | Feb 24, 2005 | Issued |
Array
(
[id] => 6945312
[patent_doc_number] => 20050197361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors'
[patent_app_type] => utility
[patent_app_number] => 11/066899
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33963
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20050197361.pdf
[firstpage_image] =>[orig_patent_app_number] => 11066899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/066899 | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors | Feb 24, 2005 | Issued |
Array
(
[id] => 5120723
[patent_doc_number] => 20070142438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine d3 receptors'
[patent_app_type] => utility
[patent_app_number] => 10/598200
[patent_app_country] => US
[patent_app_date] => 2005-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54473
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598200 | Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors | Feb 20, 2005 | Issued |
Array
(
[id] => 5101899
[patent_doc_number] => 20070185161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/598330
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21610
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598330
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598330 | Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators | Feb 17, 2005 | Issued |
Array
(
[id] => 919804
[patent_doc_number] => 07320990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-22
[patent_title] => 'Crystalline form of a biphenyl compound'
[patent_app_type] => utility
[patent_app_number] => 11/057009
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20543
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/320/07320990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11057009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/057009 | Crystalline form of a biphenyl compound | Feb 10, 2005 | Issued |
Array
(
[id] => 7056469
[patent_doc_number] => 20050277644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Pyridine analogs as C5a antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/053623
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11214
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277644.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053623 | Pyridine analogs as C5a antagonists | Feb 7, 2005 | Issued |
Array
(
[id] => 6959611
[patent_doc_number] => 20050215585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril'
[patent_app_type] => utility
[patent_app_number] => 11/053072
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3269
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215585.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053072 | Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril | Feb 6, 2005 | Issued |
Array
(
[id] => 243473
[patent_doc_number] => 07589208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Compositions containing quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/050441
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050441 | Compositions containing quinoline compounds | Feb 3, 2005 | Issued |
Array
(
[id] => 243473
[patent_doc_number] => 07589208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Compositions containing quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/050441
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050441 | Compositions containing quinoline compounds | Feb 3, 2005 | Issued |
Array
(
[id] => 243473
[patent_doc_number] => 07589208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Compositions containing quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/050441
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050441 | Compositions containing quinoline compounds | Feb 3, 2005 | Issued |
Array
(
[id] => 243473
[patent_doc_number] => 07589208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Compositions containing quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/050441
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050441 | Compositions containing quinoline compounds | Feb 3, 2005 | Issued |
Array
(
[id] => 556594
[patent_doc_number] => 07468378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-23
[patent_title] => 'Substituted quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/049852
[patent_app_country] => US
[patent_app_date] => 2005-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44968
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/468/07468378.pdf
[firstpage_image] =>[orig_patent_app_number] => 11049852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/049852 | Substituted quinoline compounds | Feb 2, 2005 | Issued |
Array
(
[id] => 7051358
[patent_doc_number] => 20050187245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Stable amorphous forms of montelukast sodium'
[patent_app_type] => utility
[patent_app_number] => 11/048746
[patent_app_country] => US
[patent_app_date] => 2005-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7622
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187245.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048746
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048746 | Stable amorphous forms of montelukast sodium | Feb 2, 2005 | Issued |
Array
(
[id] => 827008
[patent_doc_number] => 07402674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => '7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments'
[patent_app_type] => utility
[patent_app_number] => 11/042023
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10490
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402674.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042023 | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments | Jan 24, 2005 | Issued |
Array
(
[id] => 591021
[patent_doc_number] => 07435823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/042634
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94409
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042634 | Compounds and methods of use | Jan 23, 2005 | Issued |
Array
(
[id] => 7595431
[patent_doc_number] => 07626030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/042398
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32798
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/626/07626030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042398
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042398 | Compounds and methods of use | Jan 23, 2005 | Issued |
Array
(
[id] => 292510
[patent_doc_number] => 07544803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Vanilloid receptor ligands and their use in treatments'
[patent_app_type] => utility
[patent_app_number] => 11/041173
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17269
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041173 | Vanilloid receptor ligands and their use in treatments | Jan 20, 2005 | Issued |
Array
(
[id] => 7234082
[patent_doc_number] => 20050256157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Combination therapy with CHK1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/041191
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 150877
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256157.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041191 | Combination therapy with CHK1 inhibitors | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7234082
[patent_doc_number] => 20050256157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Combination therapy with CHK1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/041191
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 150877
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256157.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041191 | Combination therapy with CHK1 inhibitors | Jan 20, 2005 | Abandoned |